These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12886641)

  • 1. [Epidemiological and economic effectiveness of immunization of adult and children against influenza and acute respiratory viral infections with the vaccine Grippol].
    Khaitov RM; Nekrasov AV; Puchkova NG; Ivanova AS
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (3):83-6. PubMed ID: 12886641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the effectiveness of influenza trivalent polymer subunit vaccine "Grippol"].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Pavlova LI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Belashev VP; Malinovskiĭ AA
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (3):40-3. PubMed ID: 9700880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics of autoantibodies in elderly persons in the process of vaccination with Grippol and multicomponent vaccine VP-4].
    Egorova NB; Semenov BF; Kurbatova EA; Iastrebova NE; Poddubikov AV; Efremova VN; Semenova IB
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (5):29-35. PubMed ID: 12524997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of multiplicity of immunizations of children with inactivated influenza vaccine on immune response and the effectiveness of protection].
    Slobodniuk AV; Romanenko VV; Utnitskaia OS; Motus TM; Pereverzev AV
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (4):36-9. PubMed ID: 12449696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prophylactic efficacy of the trivalent polymer-subunit influenza vaccine Grippol (3)].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Pavlova LI; Malinovskiĭ AA
    Voen Med Zh; 1997 Feb; 318(2):47-9. PubMed ID: 9148581
    [No Abstract]   [Full Text] [Related]  

  • 6. [The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer-subunit influenza vaccine administered to schoolchildren].
    El'shina GA; Gorbunov MA; Bektimirov TA; Lonskaia NI; Pavlova LI; Nikul'shin AA; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):50-4. PubMed ID: 10808574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunostimulating activity of polycomponent vaccine "Immunovac-VP-4" and grippol after their combined administration].
    Kurbatova EA; Semenov BF; Egorova NB; Efremova VN; Gruber IM; Semenova IB; Kushchenko OM
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):34-9. PubMed ID: 15346947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity and mortality of the Russian population from acute respiratory viral infections, pneumonia and vaccination.
    Bilichenko TN; Chuchalin AG
    Ter Arkh; 2018 Feb; 90(1):22-26. PubMed ID: 30701753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Total immunization of children against influenza decreases morbidity in a number of diseases among elderly persons during influenza epidemic].
    Gendon IuZ; Kaira AN; El'shina GA; Akhmadulina RR
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (5):62-7. PubMed ID: 15554316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study.
    Salleras L; Domínguez A; Pumarola T; Prat A; Marcos MA; Garrido P; Artigas R; Bau A; Brotons J; Bruna X; Català P; Carreras E; Cuadra D; Gatell A; Millet S; Oller J; Raga E
    Vaccine; 2006 Nov; 24(44-46):6638-42. PubMed ID: 16842892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific prophylaxis of influenza in organized groups of children with the vaccine Vaxigrip].
    Zaplatnikov AL
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (6):36-40. PubMed ID: 11881493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of influenza vaccination of healthy children.
    Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
    Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An evaluation of the epidemiological and economic efficacy of immunizing adults with the Vaxigrippe vaccine].
    Sharipova IS; Kuz'minykh SI; Fel'dblium IV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):46-9. PubMed ID: 9783400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative evaluation of the reactogenicity and immunogenicity of inactivated influenza vaccines in the elderly].
    Burtseva EI; Slepushkin AN; Vlasova LN; Oskerko TA; Fedorova GI; Stepnova AI; Beregovskiĭ NA
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):40-5. PubMed ID: 11220963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
    Yang MC; Tan EC; Su JJ
    Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old].
    Rudenko LG; Grigor'eva EP; Drinevskiĭ VP; Koval' TA; Doroshenko EM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):41-6. PubMed ID: 2970743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of studying the effectiveness of a live influenza vaccine for peroral use on preschool and schoolchildren].
    Slepushkin AN; Dukova VS; Kalegaeva VA; Kagan AN; Temriuk EE
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Dec; (12):24-9. PubMed ID: 4281595
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
    Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
    JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health and economic impact of the seasonal influenza vaccination programme in England.
    Baguelin M; Jit M; Miller E; Edmunds WJ
    Vaccine; 2012 May; 30(23):3459-62. PubMed ID: 22446636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States.
    Caspard H; Gaglani M; Clipper L; Belongia EA; McLean HQ; Griffin MR; Talbot HK; Poehling KA; Peters TR; Veney N; Ambrose CS
    Vaccine; 2016 Jan; 34(1):77-82. PubMed ID: 26589519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.